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SUMMARY 1 
 2 
Objectives: Cardiac involvement in the course of acute kidney injury (AKI) is described in humans as 3 
cardiorenal syndrome type 3 but has received only limited attention in dogs. This study was designed to 4 
evaluate cardiac injury and dysfunction in canine AKI and their association with outcome.  5 
 6 
Methods: This prospective cohort study enrolled 25 client-owned dogs with AKI. Cardiac manifestations 7 
were evaluated with thoracic radiographs, echocardiography, 24h Holter monitoring and cardiac troponin I 8 
concentrations (cTnI) at admission and 7-10 days later. 9 
 10 
Results: Most dogs were diagnosed with leptospirosis (n=19, 76%) and presented with moderate to severe 11 
AKI, IRIS grades III–V. Dogs with ≥100 ventricular premature complexes (VPCs) per 24h in the first 12 
examination (n=9) had significantly higher initial cTnI concentrations (P=0.005) and a worse outcome 13 
(P=0.040) compared to dogs with fewer VPCs. In ROC curve analysis, the number of VPCs was more 14 
predictive of outcome (AUC 0.85, P<0.001) than cTnI concentrations (AUC 0.78, P=0.022). 15 
 16 
Clinical significance: AKI seems to be associated with cardiac injury and dysfunction in dogs. The data did 17 
not indicate a cardiac cause of poor outcome in dogs with increased VPCs, but an association possibly 18 
reflecting the severity of the disease. 19 
 20 
Keywords: Acute kidney injury, arrhythmias, Holter monitoring, cardiac troponin I, echocardiography 21 
22 
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INTRODUCTION 23 
The interplay between the cardiovascular and renal systems involves multiple shared mechanisms related to 24 
volume regulation and adaptive responses to loss of function. Most kidney diseases may thus be expected to 25 
have direct or indirect cardiovascular effects that may include systemic hypertension, left ventricular 26 
hypertrophy, fluid volume dysregulation, as well as manifestations of the underlying disease or iatrogenic 27 
complications (Bagshaw et al. 2013, Ronco et al. 2008). When the primary condition is acute kidney injury 28 
(AKI), these interactions are termed acute renocardiac syndrome or cardiorenal syndrome type 3 in people. 29 
Several studies suggest that this syndrome also affects dogs (Mastrorilli et al. 2007, Porciello et al. 2008, 30 
Sharkey et al. 2009). 31 
Cardiac diseases may be of functional or structural nature. Cardiac arrhythmias reflect functional 32 
myocardial disorders and long-term Holter electrocardiographic monitoring is typically indicated for their 33 
reliable quantification (Lipski et al. 1976, Marino et al. 1994, Meurs et al. 2001, Miller et al. 1999, Wess et 34 
al. 2010). Serum cardiac troponin concentration is regarded as the most accurate blood test for the evaluation 35 
of myocardial damage, with cardiac troponin I (cTnI) being the most sensitive (Adams et al. 1993, Schober et 36 
al. 2002, Shaw et al. 2004). Veterinary studies indicate that a large number of noncardiac diseases, including 37 
renal failure (Porciello et al. 2008, Sharkey et al. 2009), leptospirosis (Mastrorilli et al. 2007), babesiosis 38 
(Lobetti et al. 2002), ehrlichiosis (Diniz et al. 2008), immune-mediated haemolytic anaemia (Gow et al. 39 
2011), snake envenomation (Segev et al. 2008), pyometra (Pelander et al. 2008), systemic inflammation 40 
(Langhorn et al. 2013) and gastric dilatation volvulus (Burgener et al. 2006), may induce myocardial injury 41 
and increased cTnI concentrations. In addition, several human studies have suggested that cTnI concentrations 42 
may be affected by decreased renal clearance (Diris et al. 2004, Fahie-Wilson et al. 2006) and haemodialysis 43 
(Assa et al. 2013, Deleaval et al. 2006, Farkouh et al. 2003, Tun et al. 1998, Wayand et al. 2000), but these 44 
findings remain controversial.  45 
To the authors’ knowledge, only few studies have reported cardiac involvement in canine kidney 46 
disease, and these were limited to demonstrating elevated cTnI concentrations (Mastrorilli et al. 2007, 47 
Porciello et al. 2008, Sharkey et al. 2009). However, without further cardiologic evaluation, the clinical 48 
relevance of these findings remains unclear. The goal of the present study was to evaluate the presence of 49 
functional and structural cardiac injury in dogs with AKI using Holter recordings, cTnI measurements, 50 
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thoracic radiographs and echocardiography, and to assess possible associations between these findings and 51 
outcome. We hypothesized that AKI is associated with cardiac arrhythmias and elevated cTnI concentrations, 52 
and that cardiac injury may indicate severe disease and increased mortality.  53 
 54 
MATERIALS AND METHODS 55 
Animals 56 
Dogs diagnosed with AKI between April and December 2013 were enrolled in this prospective cohort study. 57 
Small dogs weighing less than 7kg and dogs with dyspnoea were excluded due to the size of the Holter 58 
recorder and the potential breathing impairment caused by the recorder attachment system. Other exclusion 59 
criteria were chronic kidney disease and pre-existing heart disease, as well as splenic disease or pancreatitis, 60 
which have been associated with myocardial injury (Marino et al. 1994, Serra et al. 2010). The diagnosis of 61 
AKI required at least 2 of the following criteria: renal azotaemia persisting for ≥24h after correction of 62 
prerenal factors, an increase in serum creatinine concentration ≥100 µmol/L or ≥100% from baseline, 63 
persistent oligoanuria after volume repletion; and evidence of tubular injury based on urinalysis (Fraune et al. 64 
2013). All procedures were conducted in accordance with the Animal Welfare Act (xx), and subject to 65 
informed owner consent. 66 
 67 
Diagnostic examinations and grouping 68 
Initial diagnostics included a complete blood count, biochemical and coagulation profiles, venous blood gas 69 
analysis, urinalysis, and abdominal ultrasound. Additional diagnostics, performed as indicated to identify the 70 
aetiology, included microscopic agglutination test (MAT) using a panel of ubiquitous and locally prevalent 71 
serovars (L. interrogans serovars Australis, Autumnalis, Bataviae, Bratislava, Canicola, Hardjo, 72 
Icterohaemorrhagiae, Pomona, Pyrogenes, Sejroe, and Tarassovi and L. kirschneri serovar Grippotyphosa) 73 
and a Leptospira IgM assay (Test-it lateral flow, LifeAssay Diagnostics, Cape Town, South Africa (Abdoel et 74 
al. 2011)). A diagnosis of leptospirosis was confirmed by either a 4-fold titre increase on paired serologies, a 75 
single MAT titre ≥1:800 for non-vaccine serovars, or a positive IgM assay (Schuller et al. 2015). 76 
Cardiac evaluation, performed within 48h of presentation, included physical examination, thoracic 77 
radiographs evaluated by a board-certified radiologist, transthoracic echocardiography performed by a board-78 
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certified cardiologist, 24h Holter monitoring and serum cTnI concentrations. Echocardiography was 79 
performed with an Aloka ProSound Alpha 5SV machine and a 5-MHz sector transducer in unsedated dogs. 80 
Serum samples were stored at -80°C and batched for measurements of cTnI concentrations (Centaur XP TnI-81 
Ultra assay, Siemens Healthcare Diagnostics, Eschborn, Germany) (Beck et al. 1997). The measurement 82 
range was 0.006―50 ng/mL and the laboratory upper reference limit was 0.06 ng/mL (Serra et al. 2010). 83 
Holter monitoring was performed using a 2-channel CardioMem CM 3000 recorder and the CardioDay 84 
software (GETEMED, Teltow, Germany). All recordings were subsequently checked manually by the same 85 
examiner (XX). Holter recording and cTnI measurement was repeated 7-10 days after the initial examination. 86 
The dogs were grouped based on the number of ventricular premature complexes (VPCs) during the 87 
first examination into Group 1 (<100 VPCs/24h) or Group 2 (≥100 VPCs/24h). This cut-off was chosen as it 88 
has been suggested as pertinent to detect relevant arrhythmias in previous studies (Hall et al. 1991, Meurs et 89 
al. 2001, Olsen et al. 1999, Ulloa et al. 1995, Wess et al. 2010). 90 
 91 
Treatment and outcome 92 
Therapy was adapted individually to the clinical needs of the dogs and consisted mainly of intravenous fluids, 93 
gastric protectants, antemetics, analgesics, antibiotics, and antihypertensives. In addition, dogs received renal 94 
replacement therapy as intermittent haemodiafiltration when this was indicated based on clinical condition, 95 
degree of azotaemia, potassium concentration and urine production. The outcome was defined as either fatal 96 
(death or euthanasia), full recovery (discharge without residual azotaemia) or partial recovery (discharge with 97 
persisting azotaemia). 98 
 99 
Statistical analyses 100 
Statistical analyses were performed using commercial software (MedCalc 13.0.6.0, Ostend, Belgium; NCSS 101 
9.0.15, Kaysville, Utah, USA). A sample size calculation was performed to estimate the number of dogs 102 
needed to show an increased number of VPCs (from 10 ± 5 to a mean ≥100 VPCs/24h) and an elevated 103 
concentration of cTnI (from 0.092 ± 0.066 to a mean ≥0.2 ng/ml), using previously published populations of 104 
normal dogs as references (Maier et al. 2010, Meurs et al. 2001). Samples of 6 (VPCs) and 11 dogs (cTnI) 105 
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were identified as necessary to show these differences with a 90% power, and the study was therefore 106 
designed to include the first 25 eligible dogs. 107 
Comparison of categorical data was performed using Fisher’s exact test. Continuous data were 108 
assessed for normality with normal probability plots and D’Agostino-Pearson test. Comparison between 109 
groups for continuous data was performed using independent samples t-tests when normally distributed and 110 
Mann-Whitney tests otherwise. Comparison between the first and second cTnI concentrations was performed 111 
using a Wilcoxon signed-rank test. Correlation between cTnI concentrations and creatinine was evaluated 112 
using Spearman’s rank correlation. Prediction of outcome based on cTnI concentrations or VPCs was 113 
evaluated using ROC curve analysis and the optimal cut-off based on the Youden index. Significance was set 114 
at P<0.05 throughout.  115 
 116 
RESULTS 117 
Dogs and general diagnostic evaluation 118 
During the 9 months of the study, 70 dogs were diagnosed with AKI at the authors’ institution. Twenty-five 119 
dogs met the inclusion criteria and were enrolled (Table 1). These were 7 mixed breed dogs and 18 dogs from 120 
12 different breeds. Nineteen of the 25 dogs (76%) were diagnosed with leptospirosis based on paired MAT 121 
seroconversion (n=11, 58%), positive MAT titre at presentation (n=13, 68%), or a positive IgM assay at 122 
presentation (n=13, 68%). Positive serovars in the first MAT serology (n=19) included Australis (68%), 123 
Bratislava (58%), Pomona (16%), and Autumnalis (11%). Other causes of AKI included anaesthesia-related 124 
ischaemia (n=1), renal thrombosis (n=1), grape toxicity (n=1), unidentified toxic nephrosis (n=1), and 125 
unknown aetiology (n=2). 126 
The level of azotaemia at presentation ranged from mild to severe with serum creatinine and urea 127 
concentrations ranging between 294—1359 µmol/L and 20—106 mmol/L, respectively (Table 2). Six dogs 128 
(24%) were classified as IRIS AKI grade III, 8 dogs (32%) grade IV, and 11 dogs (44%) grade V. 129 
Abnormalities found on routine bloodwork included anaemia (n=13; 52%), leukocytosis (n=17; 71%), 130 
left shift (n=10; 42%), hyperbilirubinaemia (n=10; 40%), hyperkalaemia (n=7; 28%), hypokalaemia (n=9; 131 
36%), total hypercalcaemia (n=8; 32%), ionized hypocalcaemia (n=9; 38%), hyperphosphataemia (n=25; 132 
100%), acidaemia (n=9; 38%), metabolic acidosis (n=10; 42%), and increased anion gap (n=18; 75%) (Table 133 
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2). No differences between the groups were found for any of the parameters analysed (Table 2). Urinalysis 134 
was available for 22 dogs and revealed proteinuria (n=17; 77%) and renal glucosuria (n=17; 77%). 135 
Abdominal ultrasonography supported the diagnosis of AKI with normal renal architecture, 136 
renomegaly, and perirenal effusion. No evidence of chronic kidney disease, pancreatitis or splenic disease was 137 
observed. 138 
 139 
Cardiac evaluation 140 
At initial physical examination all dogs were considered normovolaemic and a grade II-III left-sided systolic 141 
heart murmur was identified in 3 dogs. Thoracic radiographs did not show any abnormal cardiac-related 142 
findings. However, 9/19 (47%) dogs with leptospirosis demonstrated evidence of pulmonary haemorrhage 143 
with peribronchial cuffing and moderate interstitial to alveolar lung patterns. 144 
Initial echocardiographic examination was performed on all but one dog, considered too unstable to be 145 
evaluated. One dog was considered hypovola mic, based on reduced filling of the left heart, and all others 146 
were considered normovolaemic. Valvular insufficiency was observed in 15 dogs (63%), including both 147 
atrioventricular valves in 6 dogs (25%), mitral valve alone in 5 dogs (21%), tricuspid and pulmonic valves in 148 
3 dogs (13%), and pulmonic valve alone in 1 dog (4%). All other echocardiographic parameters were within 149 
normal limits in all dogs. 150 
Holter monitoring was performed in all 25 dogs at initial evaluation and in 21 dogs surviving for the 151 
second evaluation. One recording at the second evaluation contained only 6h of readable data and was 152 
excluded. During the first evaluation, VPCs were detected in 20 dogs (80%); 16 dogs (64%) had <100 153 
VPCs/24h (Group 1) and 9 dogs (36%) ≥100 VPCs/24h (Group 2) (Table 3). No other arrhythmias were 154 
identified and antiarrhythmic therapy was not considered indicated in any dog. No difference was found 155 
between the groups for any of the signalment, disease, clinical or laboratory parameters evaluated (Tables 1 156 
and 2). However, initial cTnI concentration was increased in 23 dogs (92%) and was significantly higher in 157 
Group 2 than in Group 1 (Table 3, Figure 1). No correlation was observed between the initial cTnI and 158 
creatinine concentrations (rs=0.229; P=0.270). 159 
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During the second evaluation, VPCs were detected in 11/20 dogs (55%); 17 dogs (85%) had <100 160 
VPCs/24h and 3 dogs (15%) ≥100 VPCs/24h. The cTnI concentrations were significantly lower compared to 161 
the first evaluation (P=0.008). No difference was found between groups for both parameters (Table 3). 162 
 163 
Treatment and Outcome 164 
Seventeen dogs (68%) required renal replacement therapy, a treatment not associated with a difference in the 165 
number of VPCs (P=0.192), initial cTnI concentrations (P=0.336) or outcome (P=0.621). 166 
Twenty dogs (80%) recovered from their disease and were discharged from hospital, 8 dogs with 167 
complete and 12 dogs with partial recovery. Of dogs not surviving, 3 were euthanized and 2 died. Main causes 168 
of fatal outcome included severe pulmonary haemorrhages (n=2), persistent seizures (n=2), and lack of renal 169 
recovery (n=2). Necropsy was performed in 2 dogs and revealed interstitial nephritis and thrombi in multiple 170 
organs in one dog and acute tubular necrosis and interstitial nephritis in the other. Both hearts were 171 
macroscopically and histologically unremarkable. 172 
Mortality was significantly higher in Group 2 than in Group 1 (P=0.04, Figure 2). Although initial 173 
cTnI concentrations were higher in dogs that died (median 1.75 ng/ml; range 0.28—47.15) than in survivors 174 
(median 0.39 ng/ml; range 0.04—3.07), this difference was not statistically significant (P=0.057). Based on 175 
ROC curve analysis (Figure 3), the number of VPCs/24h at presentation was predictive of outcome with an 176 
AUC of 0.85 (95% CI, 0.65—0.96, P<0.001) and a calculated optimal cut-off of 18 VPCs/24h (sensitivity 177 
100%, specificity 70%). Initial cTnI concentrations were also predictive of outcome with an AUC of 0.78 178 
(95% CI, 0.57-0.92, P=0.023) and a calculated optimal cut-off of 0.65 ng/ml (sensitivity 80%, specificity 179 
70%). 180 
 181 
DISCUSSION 182 
Data from the present study indicate that functional and structural myocardial injuries commonly occur in 183 
canine AKI. Although none of the fatalities seemed to be directly cardiac related, increased numbers of VPCs 184 
were associated with higher mortality, suggesting an indirect association or a common cause. Disease severity 185 
was not obviously different between the groups but the study was not designed and powered to examine this 186 
aspect.  187 
Page 7 of 20
Journal of Small Animal Practice
Journal of Small Animal Practice
Review Copy
 8 
Previous studies evaluating dogs with non-renal diseases found similar associations between short-188 
time electrocardiography, cTnI, and outcome (Diniz et al. 2008, Lobetti et al. 2002, Schober et al. 2002). To 189 
avoid over-interpretation of small numbers of VPCs, a cut-off of 100/24h was used in the present study. 190 
Although this is clearly higher than numbers expected in healthy dogs (10 ± 5 VPCs/24h), similar cut-offs 191 
(100-150 VPCs/24h) have been used to detect clinically relevant disease in breeds prone to arrhythmias  (Hall 192 
et al. 1991, Olsen et al. 1999, Ulloa et al. 1995, Wess et al. 2010). 193 
Valvular insufficiencies were observed in 63% of the dogs from the present study. However, these 194 
were minimal and not associated with structural alterations of the heart chambers and were, therefore, not 195 
expected to cause relevant myocardial injury (O'Brien et al. 2006, Spratt et al. 2005). Cardiac changes 196 
associated with AKI, including left ventricular hypertrophy in rats (Burchill et al. 2008) or impaired systolic 197 
function in humans (Bagshaw et al. 2013), were not observed in the present study. 198 
Acute kidney injury may increase the risk for cardiac injury by inducing pro- and anti-inflammatory 199 
cytokines and activating the sympathetic and renin-angiotensin-aldosterone systems (Bagshaw et al. 2013). 200 
Furthermore, metabolic disturbances characteristic of AKI, including acidaemia, hyperkalaemia, 201 
hypocalcaemia, hyperphosphataemia, azotaemia, and anaemia, may have profound effects on myocardial 202 
electrical activity and function (Bagshaw et al. 2013, Serra et al. 2010, Zeidman et al. 2004). Although no 203 
significant difference was found between groups for any of these parameters in the present study, this could, at 204 
least in part, be due to small sample sizes and different pre-referral therapeutic interventions. As population 205 
size was designed to address power with regards to the principal aims of the study, further investigations 206 
should evaluate the role of these factors in AKI-related myocardial injury. Overzealous fluid therapy has been 207 
described to predispose to VPCs and impaired myocardial performance (Bagshaw et al. 2013, Ip et al. 2011). 208 
However, this was unlikely a factor in the present study, based on physical examination, thoracic radiographs 209 
and echocardiography. 210 
A great number of dogs required renal replacement therapy, and this intervention may increase the 211 
risk of hypotension, hypovolaemia and rapid electrolyte and fluid shifts and therefore cause myocardial injury 212 
(Selby et al. 2007). Haemodiafiltration may further affect cTnI concentrations by partial clearance of this 24-213 
kDa molecule (Tattersall 2007, Wayand et al. 2000). However, the short half-life of cTnI (approximately 2h) 214 
(Katus et al. 1989), the timing of expected increase (4-12h after cardiac injury) (Goldmann et al. 2001), and 215 
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the timing of blood sampling (prior to the first treatment and ≥4d after the last treatment) make it unlikely that 216 
dialysis affected cTnI concentrations in the present study (Assa et al. 2013, Deleaval et al. 2006, Farkouh et 217 
al. 2003, Tun et al. 1998).  218 
Decreased renal clearance has also been suggested to increase cTnI concentrations. However, the 219 
absence of correlation between azotaemia and cTnI in the present study suggests that this did not play a major 220 
role in cTnI elevations, paralleling results from other studies (Ellis et al. 2001, Mastrorilli et al. 2007, 221 
Porciello et al. 2008, Van Lente et al. 1999). Based on these considerations, data in the present study support 222 
the hypothesis of a real and severe myocardial injury associated with canine AKI (Gallegos et al. 2004, 223 
Ricchiuti et al. 1998). 224 
Leptospirosis has been shown to affect the cardiovascular system and has been associated with 225 
arrhythmias, increased cTnI concentrations, and myo-, endo-, or pericarditis (Mastrorilli et al. 2007, Skerk et 226 
al. 2011). Given that 76% of the dogs in the present study were diagnosed with leptospirosis, the extent to 227 
which myocardial injury was due to AKI itself or due to leptospirosis remains unclear. 228 
In conclusion, the results of the present study confirm our hypotheses that AKI is associated with 229 
cardiac arrhythmias and substantial but reversible myocardial injury. The worse outcome for affected animals 230 
is likely multifactorial and may result from higher disease severity, but this could not be substantiated in the 231 
present study. Further studies focusing on the inflammatory and the neuro-endocrine status of canine AKI are 232 
necessary to evaluate more precisely the possible pathophysiologic processes responsible for these cardiorenal 233 
effects.  234 
 235 
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Figure legends 352 
 353 
Figure 1. Bar chart showing the median (95% confidence intervals) for cTnI concentrations in the 2 groups of 354 
dogs: group 1, 16 dogs with AKI and <100 VPCs/24h; group 2, 9 dogs with AKI and ≥100 VPCs/24h. 355 
 356 
Figure 2. Frequency chart showing outcome in the 2 groups of dogs: group 1, 16 dogs with AKI and <100 357 
VPCs/24h; group 2, 9 dogs with AKI and ≥100 VPCs/24h. 358 
 359 
Figure 3. ROC curves representing the predictive value of the parameters VPCs (AUC 0.85) and cTnI (AUC 360 
0.78) on outcome for dogs with AKI. 361 
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Table 1. Clinical data in dogs with acute kidney injury and <100 VPCs/24h (Group 1) 
or ≥100 VPCs/24h (Group 2). 
 
Variable All dogs (n=25) Group 1 (n=16) Group 2 (n=9) P-value 
Gender 
Male [n (%)] 16 (64%) 
9 (36%) 
10 (63%) 
6 (37%) 
6 (67%) 
3 (33%) 
1.000 
Female [n (%)] 
Body weight, kg [median (range)] 25.1 (7.2―57.0) 21.5 (7.2―57.0) 26.3 (11.8―47.6) 0.396 
Age, years [median (range)] 6.7 (0.3―13.5) 5.6 (0.3―13.5) 8.5 (0.4―12.1) 0.536 
Leptospirosis [n (%)] 19 (76%) 13 (81%) 6 (67%) 0.630 
Pulmonary haemorrhage [n (%)] 9 (36%) 5 (31%) 4 (44%) 0.671 
Renal replacement therapy [n (%)] 16 (64%) 9 (56%) 7 (78%) 0.401 
Survival at 90 days [n (%)] 20 (80%) 15 (94%) 5 (56%) 0.040 
VPCs ventricular premature complexes. 
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Table 2. Median (25th-75th percentile) of laboratory data in dogs with acute kidney 
injury and <100 VPCs/24h (Group 1) or ≥100 VPCs/24h (Group 2). 
 
Parameter All dogs (n=25) Group 1 (n=16) Group 2 (n=9) P-value 
Hematocrit (L/L) 0.39 (0.33—0.44) 0.39 (0.34—0.43) 0.36 (0.32—0.47) 0.909 
WBC (x10
9
/L) 14.22 (11.57—21.59) 13.66 (11.55—20.67) 15.68 (12.85—21.18) 0.387 
Creatinine ( µmol/L) 748 (492—1082) 704 (463—1095) 892 (548—1069) 0.711 
Urea (mmol/L) 57.69 (42.63—62.71) 47.00 (40.26―61.33) 59.54 (53.82―66.62) 0.428 
Na (mmol/L) 145 (143—148) 144 (142—148) 147 (143—149) 0.410 
K (mmol/L) 4.61 (3.96—5.6) 4.58 (4.03—5.49) 5.18 (3.93—5.60) 0.737 
P (mmol/L) 4.27 (2.69—6.03) 4.32 (2.42—5.60) 4.09 (3.36—6.45) 0.692 
Total Ca (mmol/L) 2.62 (2.31—2.89) 2.52 (2.20—2.87) 2.71 (2.56—3.03) 0.174 
Ionized Ca (mmol/L) 1.14 (1.03—1.24) 1.16 (1.02—1.26) 1.09 (1.04—1.21) 0.788 
pH 7.34 (7.29—7.37) 7.36 (7.31—7.37) 7.31 (7.29—7.34) 0.144 
HCO3
-
 (mmol/L) 19.0 (17.1—21.6) 19.6 (18.0—21.7) 17.5 (16.6—19.7) 0.449 
PCO2 (mmHg) 36.2 (34.9—40.0) 36.3 (35.2—39.1) 35.5 (33.5—40.8) 0.644 
 
VPCs ventricular premature complexes, WBC white blood cell count. 
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Table 3. Concentrations of cTnI and 24h-Holter monitoring in dogs with acute kidney 
injury and <100 VPCs/24h (Group 1) or ≥100 VPCs/24h (Group 2) at initial 
examination 
 
Time Parameter All dogs Group 1 Group 2 P-value 
T0 
Number of dogs (n) 25 16 9 
 
VPCs/24h [median, (IQR)] 17 (2—321) 5 (0—14) 711 (304—3183)  
cTnI, ng/mL [(median (IQR)] 0.59 (0.19—1.81) 0.29 (0.16—0.63) 1.75 (0.68—3.23) 0.005 
cTnI >reference [n (%)] 23 (92%) 14 (88%) 9 (100%) 0.520 
T1 
Number of dogs (n) 21* 14 7*  
VPCs/24h [median, (IQR)] 1 (0—50) 1 (0—17) 42 (0—854) 0.495 
<100 VPCs/24h [n (%)] 
≥100 VPCs/24h [n (%)] 
17 (85%) 
3 (15%) 
13 (93%) 
1 (7%) 
4 (67%) 
2 (33%) 
0.202 
cTnI, ng/mL [(median (IQR)] 0.22 (0.05—0.52) 0.12 (0.04—0.31) 0.23 (0.10—1.54) 0.168 
cTnI >reference [n (%)] 14 (67%) 8 (57%) 6 (86%) 0.337 
* Holter data missing due to incomplete recordings in 1 dog, cTnI cardiac troponin I, IQR interquartile 
range, T0 initial examination, T1 follow-up examination, VPCs ventricular premature complexes. 
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Bar chart showing the median (95% confidence intervals) for cTnI concentrations in the 2 groups of dogs: 
group 1, 16 dogs with AKI and <100 VPCs/24h; group 2, 9 dogs with AKI and ≥100 VPCs/24h.  
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Frequency chart showing outcome in the 2 groups of dogs: group 1, 16 dogs with AKI and <100 VPCs/24h; 
group 2, 9 dogs with AKI and ≥100 VPCs/24h.  
214x173mm (300 x 300 DPI)  
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ROC curves representing the predictive value of the parameters VPCs (AUC 0.85) and cTnI (AUC 0.78) on 
outcome for dogs with AKI.  
196x180mm (300 x 300 DPI)  
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